Clinical access to genomic information in Europe - European Medical Journal

Clinical access to genomic information in Europe


Genomic interventions may improve disease-risk stratification and patient-tailored treatment. At the European Cancer Congress (ECC) 2015, John Crown, MD, MBA, of St Vincent’s University Hospital, Dublin, Ireland, outlines the processes and challenges surrounding the health economic evaluation of genomic technologies in Europe. Clinical trials, such as the prospective validation of a 21-gene expression assay in breast cancer (Trial Assigning IndividuaLized Options for Treatment, TAILORx), are providing the data necessary to define the clinical utility of genomic profiling tests.

This content is supported by Genomic Health, Inc.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now